Biosimilar Newsletter Archive

  1. 06.11.26 -- Process Intensification: Your Guide To "Doing More With Less" 6/11/2026
    06/11/26 Biosimilar Development Newsletter
  2. 06.04.26 -- Are Biotechs Wasting Time On The Wrong CDMO? 6/4/2026
    06/04/26 Biosimilar Development Newsletter
  3. 05.21.26 -- Minimizing Regulatory Risk For Biologics Manufacturing Changes 5/21/2026
    05/21/26 Biosimilar Development Newsletter
  4. 05.14.26 -- Do Changes Signal The End Of Biosimilar Regulatory Redundancy? 5/14/2026
    05/14/26 Biosimilar Development Newsletter
  5. 05.07.26 -- The Business Case For Continuous Manufacturing In Biologics 5/7/2026
    05/07/26 Biosimilar Development Newsletter
  6. 04.30.26 -- Quantifying Single-Use Waste Produced During mAb Manufacture 4/30/2026
    04/30/26 Biosimilar Development Newsletter
  7. 04.16.26 -- Innovation That's Redefining Aseptic Filling 4/16/2026
    04/16/26 Biosimilar Development Newsletter
  8. 04.16.26 -- How Biopharma Continues To Grapple With Annex 1 4/16/2026
    04/16/26
  9. 04.09.26 -- Trends In FDA 2025 Warning Letters 4/9/2026
    04/09/26
  10. 04.02.26 -- The Hidden Engineering Behind Successful Upstream Bioprocessing 4/2/2026
    04/02/26 Biosimilar Development Newsletter